FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-005169-20-DK
Enrollment
15
Registered
2012-02-14
Start date
2012-02-14
Completion date
Unknown
Last updated
2015-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10018000 Term: Gastrointestinal pain NOS System Organ Class: 100000004856

Interventions

Trade Name: Relistor Product Name: Methylnaltrexone Pharmaceutical Form: Solution for injection/infusion CAS Number: 73232-52-7 Other descriptive name: METHYLNALTREXONE BROMIDE Concentration unit: mg/

Sponsors

Mech-Sense, Department og Gastroenterology, Aalborg Sygehus
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 25 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Denmark

Contacts

Public ContactMech-Sense

Aalborg Hospital

anne.brokjaer@rn.dk004599326247

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026